Glycemia in spontaneous intracerebral hemorrhage: Clinical implications by Alvis-Miranda, Hernando et al.
  
 
 
 
Romanian Neurosurgery (2014) XXI 3: 313 - 324         313 
 
 
 
 
 
 
 
Glycemia in spontaneous intracerebral hemorrhage: 
clinical implications 
Hernando Alvis-Miranda1, Gabriel Alcala-Cerra2, Luis Rafael 
Moscote-Salazar2 
Universidad Cartagena, Colombia 
1Cartagena de Indias; 2Neurosurgeon 
 
Abstract 
Spontaneous cerebral hemorrhage or 
intracranial hemorrhage accounts for 10-15% 
of all strokes. Intracranial hemorrhage is much 
less common than ischemic stroke, but has 
higher mortality and morbidity, one of the 
leading causes of severe disability. Various 
alterations, among these the endocrine were 
identified when an intracerebral hemorrhage, 
these stress-mediated mechanisms exacerbate 
secondary injury. Deep knowledge of the 
injuries which are directly involved alterations 
of glucose, offers insight as cytotoxicity, 
neuronal death and metabolic dysregulations 
alter the prognosis of patients with 
spontaneous intracerebral hemorrhage. 
Key words: intracranial hemorrhage, 
Glycemia, stroke, neurosurgery 
Introduction 
Spontaneous intracerebral hemorrhage 
(sICH) is a devastating and disabling disease 
(1, 2). Is the second most common form of 
stroke, representing 10-30% of first-ever 
strokes (3). Overall incidence sICH worldwide 
is 24.6 per 100,000 person-years with 
approximately 40,000 to 67,000 cases per year 
in the United States (4-7), approximately half 
of this mortality occurs within the first 24 
hours, highlighting the critical importance of 
early and effective treatment in EDs (8). 
Deleterious effect of metabolic 
derangements like hyperglycemia has been 
studied since Claude Bernard described the 
relationship between hyperglycemia and 
cerebral injury (9).  The occurrence of 
hyperglycemia is a known phenomenon in 
various types of acute cerebral injury. When 
measured at arrival to ED, hyperglycemia is 
associated with worse outcome in both 
diabetic and nondiabetic patients (10-13). 
 A high proportion of patients (about 60%) 
might develop hyperglycemia even in the 
absence of a previous history of diabetes after 
sICH (14). Increased blood glucose in the 
acute setting of sICH is probably a response to 
stress and severity of sICH (15) and can persist 
for up to 72 h after sICH (14). Declining 
glucose values after sICH are associated with a 
decreased risk of hematoma expansion and 
poor outcome, suggesting that early glucose 
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control may improve outcomes (16). Many 
studies have shown that increased serum 
glucose on admission is associated with larger 
haematoma size, expantion, perihematomal 
oedema, cell death, intraventricular extention 
(17), and increased risk of poor outcome (10, 
11, 14, 18, 19), furthermore is a potent 
predictor of 30 day mortality in both diabetic 
and non-diabetic patients with sICH as well as 
an independent predictor of early mortality 
and worse functional outcome in non-diabetic 
patients with sICH (11, 19, 20). 
Glucose and brain physiology (21-48) 
The brain is an expensive energy organ. 
Brain function requires the 15% of the cardiac 
output, consumes 20% of the oxygen and the 
25% of the total organism glucose; has a high 
tolerance to the temporal fuel deficit, because 
it only consumes approximately 33% of the 
available oxygen and a 10% of the total glucose. 
The cerebral blood flow (CBF) is the supply of 
energetic sources, in a mean of 
50mL/100g/min, with a brain oxygen 
consumption of 50cm3/min, and a similar 
carbon dioxide production, with a respiratory 
quotient near to 1, indicating that 
carbohydrates are the main substrates for the 
brain oxidative metabolism (49). 
All the different cells types in the central 
nervous system (i.e., neurons, glia and vascular 
cells) show a different metabolic glucose 
consumption rate. Virtually, the only 
metabolic fuel of the brain is glucose; under 
aerobic conditions this molecule undergoes 
glycolysis to adenosine triphosphate (ATP) 
and pyruvate. Pyruvate is converted to acetyl-
CoA via the Kreb’s cycle to generate ATP and 
reducing equivalents, this is the aerobic way, 
renders 30 moles of ATP; exists another way to 
convert glucose to ATP, the anaerobic way, but 
it is inefficient, just renders 2 moles of ATP 
through production of lactic acid.  
Glucose entre to the brain through GLUT 
family of hexose transportes; astrocytes 
express GLUT1, GLUT2, and GLUT4, 
neurons express GLUT3, GLUT4, and GLUT8 
(50). If neurons, preferentially access to 
glucose directly from the brain interstitial fluid 
or if the metabolism of glucose to lactate by 
astrocytes is a required step, is still in debate 
(51, 52).  
Brain needs glucose, but also controls the 
glucose levels when integrating information 
from peripheral receptors (53). Has been 
established that brain insulin plays a crucial 
role in the regulation of the metabolism, 
enhancing glucose uptake by astrocytes (54). 
Studies using SPECT technology have 
suggested that glucose transport and 
metabolism in human brain are dependent of 
blood supply. Has been demonstrated insulin-
mediated increases in mean global rate of 
brain glucose utilization, suggesting that 
insulin may play some role in the regulation of 
cerebral glucose, especially in the cortex (55). 
Alterations of the insulin actions in the 
brain are involved in metabolic diseases. The 
mechanisms by which glucose sensitive 
neurons detect changes in glycemia and alter 
their firing pattern are still being investigated. 
In the glucose sensing process participate the 
same proteins that control glucose signaling in 
pancreatic beta-cells (56), i.e., the GLUT2, the 
enzyme glucokinase and the ATP sensitive 
potassium channel. In the response to 
  
 
 
 
Romanian Neurosurgery (2014) XXI 3: 313 - 324         315 
 
 
 
 
 
 
 
hypoglycemia participate the AMP-activated 
protein kinase (57).  
When an injury impaired the oxidative 
phosphorylation, either lower arterial oxygen 
tension, mitochondrial dysfunction or brain 
lesions, the glycolysis is deviated to the 
anaerobic way, producing lactic acid and 
hydrogen ions, generating tissue acidosis and 
reactive species of oxygen, respectively. When 
this takes place, trigger deleterious effects in 
the neuronal cells, product of the activation of 
calcium entry to the cells, the release of 
cytotoxic free fatty acids and excitotoxic 
neurotransmitters like glutamate. Although 
the intermediate metabolites of glucose 
breakdown, pyruvate and lactate, in some 
circumstances can sustain the energy demand 
of the neuronal activity, both lack the ability to 
cross the blood-brain barrier. In pathological 
states, also are used as metabolic substrates the 
ketonic bodies. 
Brain glycogen is primarily located in the 
astrocytes (58). And its stores finishes in about 
5 minutes, when needed. In an animal model 
of type 2 diabetes mellitus, glycogen 
metabolism has been demonstrated to be 
important for supporting glutamatergic and 
GABAergic homeostasis, maintaining a 
proper ratio between excitatory and inhibitory 
neurotransmitters (59).  Different animal and 
human studies evidence a significantly 
compromised altered glucose metabolism in 
the setting of traumatic brain injury, cerebral 
ischemia and hemorrhages. Due to the 
mitochondrial membrane dysfunction during 
hypoxic and hyperglycemic insults, the cells in 
the perihemorrhagic area are unable to 
metabolise the excess of glucose, this happens 
specifically in intracerebral hemorrhage, and 
are the main phenomena to comprehend why 
hypo/hyperglycemia are so deleterious in the 
setting of an acute brain lesion. 
Hyperglycemia and the sICH 
The hyperglycemic state results from 
metabolic derangements in the glucose 
metabolism (60). In the acute phase of sICH 
develops an unspecific, programmed and 
adaptive response to the stress that induce 
activation of the hypothalamic-hypophysis-
adrenal axis and the subsequent releasing of 
hyperglycemic hormones (61-64), activation 
of the autonomous nervous system and 
changes in the behavior, everything as a part of 
the well described metabolic–hormonal 
response to stress and to the systemic 
inflammatory response syndrome (SIRS). 
In the context of a lesion, irrespective of the 
nature, the mechanism that drives to a stress 
hyperglycemia are the increased 
gluconeogenesis and insulin resistance, the 
later, may be result from impaired insulin 
receptor binding and signal transduction, 
increased hepatic glucose production, and 
decreased peripheral glucose uptake (65). 
The big final effect, a stress-induced 
hyperglycemic state, constitutes an 
aggravating factor of the lesion. Also has been 
demonstrated an independent relationship 
between the kind and the severity of the 
neurologic injury (66, 67). The surgical 
procedures also contribute to activate a 
neuroendocrine response that predispose the 
patient to develop hyperglycemia and 
ketoacidosis because its antagonizing action 
on the insulin activity (60, 63). Other well 
documented effects of stress-induced 
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hyperglycemia are the endothelial cell 
dysfunction, increased oxidative stress, 
cardiovascular effects and lesion in other 
specific brain areas (68-70). 
When the hyperglycemic state is 
stablished, it plays a range of deleterious 
mechanisms on the injured brain, through the 
increase of oxidative stress, inflammatory 
cytokines, induction of excitotoxicity [e.g., 
stimulation of the N-methyl-Daspartate 
(NMDA) receptor] potentiating the calcium 
entry to the cells, alters the brain metabolism 
and therefore the perfusion (71-73). Due to the 
above, glucose neurotoxicity   
The excessive glucose concentration in the 
lesions microenvironment induces lipid 
peroxidation, protein carbonilation, and DNA 
damage. As the superoxyde is been 
neutralizing the nitric oxide, the vasodilation 
is impaired (74, 75). As result of the 
productions of reactive species of oxygen 
(RSO), then is activated an inflammatory 
response that leads to immune cells attraction, 
and then increasing the production of EROs. 
Lactic acid is also concentrated, so is an easy 
way to turn acidotic the neuron cells, this 
acidosis alters mitochondrial function (76, 77). 
In rat models of intracerebral hemorrhage 
(78-80) have been demonstrated the 
mentioned physiopathological events, and 
higher size of hemorrhage in the 
hyperglycemic rat groups. In a recent 
experiment was observed that in response to 
the intracerebral hemorrhage lesion, 
significant increase of albumin was 
ubiquitously observed in the brains of 
normoglycemic rats but not in the brains of 
hyperglycemic rats. In the last group, more 
significant neuronal apoptosis were found in 
the perihematomal regions of hyperglycemic 
rats, suggesting a protection role of albumin in 
acute stage of intracerebral hemorrhage, 
which may be dependent on different blood 
sugar levels (81). 
Hypoglucemia and the sCHI 
Defined as glucose plasma level <50mg/dL 
(<2.8mmol/L) with/without symptoms (49). 
Currently, there is a paucity of data on cerebral 
glucose metabolism in human subjects with 
spontaneous intracerebral hemorrhage, but 
have been demonstrated that hypoglycemia, 
the other side of the coin, also worsens the 
outcome of patients with critical illness. In the 
acute injured brain, hypoglycemia could be 
particularly harmful. 
The “neurological injury glucose 
threshold” varies with some patient’s factors, 
i.e., history of diabetes mellitus, the speed of 
the glucose level drop, the duration of the 
hypoglycemia event and the cerebral blood 
flow, etc. In patients with poor-grade 
subarachnoid hemorrhage the acute 
reductions in serum glucose, even to levels 
within the normal range, could generate brain 
energy metabolic crisis and lactate/pyruvate 
ratio elevation (82). When the brain’s 
metabolism autoregulation is altered, there 
ares parts of them specially more susceptible 
than others (83-86), when could be thoughtful 
glucose level as “sufficient” in a patient whith 
acute brain lesion this might be insuffient and 
even deleterious. The brain’s compensation 
systems (release of conter-regulatory 
hormones, increase the cerebral blood flow, 
use of the glycogen storages) to the glycopenia 
are limited (87-89). The big problem with a 
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hypoglycemia state is that is associated with 
aberrant depolarization in the perilesional 
tissue that drives to a perpetuating glucose 
depletion, as has been demonstrated in 
traumatic brain injury (32, 90) 
Mortality and other Outcomes 
As stated in other items of this review, the 
hyperglycemia measured in peripheral blood 
is both a marker of injury severity and of poor 
outcome, a relationship that has captured the 
attention of clinicians over the past few years. 
Studies evaluating the association of glycemia 
derangements and sICH are scarce (10, 14), in 
comparison with other types of stroke, where 
later researches utilize multimodal 
neuromonitoring with intracerebral 
microdialysis catheters, brain oxygen 
monitors and measurements of both, 
peripheral and cerebral blood glucose. 
Kimura and colleagues with a prospective 
observational study design and 100 patients 
with acute supratentorial Intracerebral 
hemorrhage, assessing clinical characteristics 
and plasma glucose. ICH volume was 
measured on admission CT (b24 h) and 
follow-up CT (b48 h) scans. Patients were 
divided into two groups: the death group, who 
died within 14 days of onset, and the survival 
group. Using receiver operating characteristic 
(ROC) curve, founded that cut-off values that 
predicted early death were 150 mg/dl for the 
glucose level and N20 ml for the initial IVH 
volume, they conclude that admission 
hyperglycemia may independently increase 
the risk of early death in acute spontaneous 
intracerebral hemorrhage (10).  
Godoy and collegues in a prospective study 
with 250 patients with a well-defined diagnosis 
of sICH admitted into 24 h in three primary 
referred centers. Patients had extensive 
monitoring of BG values and those with BG 
values >8.29 mmol/l (150 mg/dl) received a 
variable intravenous insulin dose to maintain 
BG concentrations during the first 72 h after 
sICH between 3.32 and8.29 mmol/l (60–150 
mg/dl) using pre-specified insulin dosing 
schedule protocol, and using a cutoff value of 
>164mg/dL, they conclude that hyperglycemia 
is a common condition after sICH that could 
worsen prognosis and the very early insulin 
therapy does not improve prognosis, also show 
an increased risk of poor outcomes and death. 
Stress hyperglycaemia is a common finding 
in patients presenting with intracerebral 
haemorrhage. It is a marker of poor outcomes 
and higher mortality, more so in patients with 
no known history of diabetes (91). Over the 
years ICH has been reported to have a 
mortality rate between 35–52% and poor 
functional outcome of survivors, with only 10–
20% living independently at 30 days (92-96) 
Literature has reported Glasgow Coma Scale 
(GCS) on arrival, blood pressure on 
presentation, volume of hemorrhage, 
concomitant intraventricular hemorrhage, 
previous ischemic stroke, and National 
Institutes of Health Stroke Scale (NIHSS) 
score as predictors of early mortality in 
patients with ICH (11). 
For evaluating glycaemia derangements in 
unspecific medical conditions but in critically 
ill patients a study look for evaluate the 
compared risk adjusted mortality when those 
patients were admitted to a surgical intensive 
care over 4 years.  Patients were divided into 
glycemic groups: HYPER (≥1 episode > 180 
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mg/dL, any <60), HYPO (≥1 episode < 60 
mg/dL, any >180), BOTH (≥1 episode < 60 and 
≥1 episode > 180 mg/dL), NORMO (all 
episodes 60-180 mg/dL), HYPER-Only (≥1 
episode > 180, none <60 mg/dL), and HYPO-
Only (≥ episode < 60, none >180 mg/dL). The  
mortality ratios (O/E) were studied using the 
expected Acute Physiology and Chronic 
Health Evaluation (APACHE) III. Number of 
adverse glycemic events was compared with 
mortality. Hypoglycemia and hyperglycemia 
occurred in 18 per cent and 50 per cent of 
patients. Mortality was 12.4 per cent (O/E = 
0.88). BOTH had the highest O/E ratio (1.43) 
with HYPO the second highest (1.30). Groups 
excluding hypoglycemia (NORMO and 
HYPER-only) had the lowest O/E ratios: 0.56 
and 0.88. Increasing number of hypoglycemic 
events were associated with increasing O/E 
ratio: 0.69 O/E for no events, 1.19 for 1-3 
events, 1.35 for 4-6 events, 1.9 for 7-9 events, 
and 3.13 for >/= 10 events. As result was 
observed that, ten or more hyperglycemic 
events were needed to significantly associate 
with worse mortality (O/E 1.53); and 
hyper/hypoglycemia increase mortality 
compared with APACHE III expected 
mortality, with highest mortality risk if both 
are present. In this study hypoglycemia was 
associated with worse risk, so the authors 
recommend that glucose control may need to 
be loosened to prevent hypoglycemia and 
reduce glucose variability (97). 
In a study evaluating the prognosis and 
outcome of acute stroke in an Universitary 
hospital in Nigeria, founded that age above 39 
years, male gender, systemic hypertension, 
early onset of coma after stroke, and presence 
of co-morbidities were associated with poor 
stroke outcome, the 78.8% of all stroke 
subtypes corresponded to intracerebral 
hemorrhage (98). 
The effects of parameters as elevation of 
white blood cell count (WBC), C-reactive 
protein (CRP), and blood glucose (BG) 
concentration at presentation prognosticate 
poor outcome in sICH patients were 
investigated for Di Napoli and colleagues 
conclude that higher WBC, CRP, and BG are 
associated with increased mortality in sICH 
patients, and also founded that only CRP 
elevation portends higher risk of death 
independently of other indicators of sICH 
severity (99). 
In the Acute Brain Bleeding Analysis 
Study, a korean study for evaluate the effects of 
glucose level on early and long-term mortality 
after intracerebral haemorrhage was observed 
a long-term mortality rate of 21.1% after a 
mean follow-up of 434.3 +/- 223.2 days and 
was found to increase significantly with 
glucose quartile (p < 0.001). The admission 
glucose level was an independent risk factor 
for early mortality (adjusted HR 1.10 [95% CI 
1.01-1.19]), but not for long-term mortality. 
Moreover, when analysis was restricted to 
patients without diabetes, glucose level was 
found to be an independent risk factor for 
post-ICH mortality (n = 1,119; adjusted HR 
1.10 [95% CI 1.03-1.17]) and had marginal 
significance for early (p = 0.053) and long-
term mortality (p = 0.09). From the above is 
conclusive that admission glucose levels are 
associated with early mortality after 
intracerebral hemorrhage. In patients without 
diabetes, admission glucose levels were 
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associated with long-term mortality (19).  
Kimura and colleagues have founded an 
association between hyperglycemia at 
admission to EDs and an increased risk of 
early death (10). Other worry about the 
assessment of mortality in sICH is that in 
comparison with other cerebrovascular 
diseases, there are no grading prognostic scales 
routinely used in sICH around the world. 
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